Pharmaceutical Grade

ADVAIR DISKUS 250 [FLUTICASONE PROPIONATE + SALMETEROL INHALATION POWDER 250MCG | 50MCG X 60 DOSES] – CANADIAN PHARMACEUTICAL GRADE COMBINATION RESEARCH INHALER

Advair Diskus 250 contains a dual-active combination of Fluticasone Propionate (250mcg) and Salmeterol (50mcg) per inhalation dose. It is a Canadian pharmaceutical grade dry powder inhalation system designed for research applications focused on respiratory receptor modulation, anti-inflammatory activity, and beta-2 adrenergic pathway studies.

Researchers use this formulation to evaluate the synergistic effects between corticosteroid-mediated anti-inflammatory signaling and beta-2 adrenergic receptor agonism within controlled pulmonary systems. Each device provides 60 precisely metered doses in a sealed, dry-powder delivery system.

The Details:

• Active Ingredients: Fluticasone Propionate 250mcg + Salmeterol Xinafoate 50mcg per dose

• Quantity: 60 metered doses per Diskus device

• Form: Inhalation powder (Dry Powder Inhaler – DPI)

• Source: Canadian pharmaceutical grade

Key Features of Advair Diskus 250:

• Dual Mechanism Research Tool: Combines corticosteroid and beta-2 agonist for receptor pathway comparison.

• Anti-Inflammatory Studies: Supports investigations into glucocorticoid receptor signaling and cytokine modulation.

• Adrenergic Pathway Research: Enables analysis of long-acting beta-2 receptor engagement.

• Synergistic Modeling: Designed for combined pathway studies in pulmonary response experiments.

• Canadian Verified Quality: Produced to pharmaceutical standards and third-party verified.

For more products, visit: https://www.canadasteroiddepot.is/

HUMALOG KWIKPEN 200IU/ML 5×3ML INSULIN PENS – CANADIAN PHARMACEUTICAL GRADE INSULIN ANALOG

Humalog KwikPen 200IU/mL is a Canadian pharmaceutical grade rapid-acting insulin analog (Insulin Lispro) supplied in prefilled injection pens for precision dosing and stability. This formulation is used in laboratory research to study glucose regulation, receptor activity, and metabolic signaling in controlled settings.

Each pack includes five 3mL prefilled pens, each containing 200IU/mL of high-purity Insulin Lispro. Manufactured to exacting Canadian pharmaceutical standards, every pen ensures consistent delivery and stability for extended research use.

The Details:

• Concentration: 200IU/mL

• Quantity: 5 pens × 3mL each

• Form: Prefilled injectable pens (Insulin Lispro)

• Packaging: Sterile, sealed, tamper-evident containers

• Source: Canadian pharmaceutical grade

Key Features of Humalog KwikPen:

• Insulin Receptor Studies: Supports investigations into insulin signaling and glucose uptake pathways.

• Rapid-Action Kinetics: Ideal for modeling fast-acting insulin analog activity in controlled systems.

• Consistent Delivery: Prefilled pens ensure reproducible dose precision across applications.

• Metabolic Research Utility: Enables studies on carbohydrate metabolism and energy regulation.

• Canadian Verified Quality: Authenticated and tested to pharmaceutical-grade standards.

For more products, visit: https://www.canadasteroiddepot.is/